DAX24.007 +4,7%Est505.892 +4,6%MSCI World4.343 -0,1%Top 10 Crypto9,4400 +3,4%Nas22.633 +2,8%Bitcoin60.915 -1,1%Euro1,1691 +0,8%Öl95,19 -8,0%Gold4.756 +1,1%
Beliebte Suche
DAX 40 Ölpreis Euro - Dollar Bitcoin - Euro Goldpreis
Meistgesucht
Rheinmetall 703000 Lufthansa 823212 Siemens Energy ENER6Y NVIDIA 918422 SAP 716460 Deutsche Telekom 555750 Allianz 840400 BASF BASF11 DroneShield A2DMAA Infineon 623100 Deutsche Bank 514000 Mercedes-Benz Group (ex Daimler) 710000 Microsoft 870747 Siemens 723610 RENK RENK73
Alle Aktien für 0 Euro (zzgl. Spreads) handeln mit finanzen.net zero. Hier informieren
Heute im Fokus
Deeskalation im Nahost-Konflikt: USA und Iran beschließen Waffenruhe -- DAX gewinnt letztlich über 1.000 Punkte -- Ölpreise fallen massiv -- Ölaktien, Rüstungsaktien, DroneShield im Fokus
Top News
Kursrally nach Waffenruhe: DAX erobert 24.000-Punkte-Marke letztlich zurück - Zinspolitik rückt in den Fokus Kursrally nach Waffenruhe: DAX erobert 24.000-Punkte-Marke letztlich zurück - Zinspolitik rückt in den Fokus
Webinar: Pulverfass Geopolitik - dein technischer Börsenkompass im Schatten des Iran-Konflikts Webinar: Pulverfass Geopolitik - dein technischer Börsenkompass im Schatten des Iran-Konflikts
Suche...
Login
ODER

Neu auf finanzen.net?

Kostenfrei registrieren und Vorteile nutzen

Übersicht Wertpapierdepots Musterdepots Watchlists Meine News Newsletter Forum Trading Desk Apps Social Media Podcasts
Profil

Haemonetics Aktie

Kaufen
Verkaufen
Aktien-Sparplan anlegen
51,50 EUR +0,50 EUR +0,98 %
STU
53,50 EUR +2,00 EUR +3,88 %
HAML
finanzen.net zero
Haemonetics jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Smartphone

Marktkap.2,32 Mrd. EUR

KGV19,12Div. Rendite0,00%
WKN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

WKN881782

ISIN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

ISINUS4050241003

Symbol wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

SymbolHAE

Haemonetics Aktien News

DatumMeistgelesen
ZacksUnderstanding Haemonetics (HAE) Reliance on International Revenue
BenzingaThese Analysts Slash Their Forecasts On Haemonetics After Q1 Results
BenzingaA Glimpse Into The Expert Outlook On Haemonetics Through 6 Analysts
ZacksHaemonetics (HAE) Reports Q1 Earnings: What Key Metrics Have to Say
ZacksHaemonetics (HAE) Q1 Earnings and Revenues Surpass Estimates
MotleyFoolHaemonetics (HAE) Q1 Revenue Falls 4%
PR NewswireHaemonetics 1st Quarter Fiscal Year 2026 Earnings Release Available on Investor Relations Website
ZacksUnlocking Q1 Potential of Haemonetics (HAE): Exploring Wall Street Estimates for Key Metrics
ZacksAnalysts Estimate Haemonetics (HAE) to Report a Decline in Earnings: What to Look Out for
PR NewswireHaemonetics Sets Date for Publishing First Quarter Fiscal Year 2026 Results: August 7, 2025
PR NewswireHaemonetics to Present at Goldman Sachs 46th Annual Global Healthcare Conference
BenzingaWhat 4 Analyst Ratings Have To Say About Haemonetics
ZacksHere's What Key Metrics Tell Us About Haemonetics (HAE) Q4 Earnings
ZacksHaemonetics (HAE) Q4 Earnings and Revenues Surpass Estimates
PR NewswireHaemonetics 4th Quarter and Fiscal Year 2025 Earnings Release Available on Investor Relations Website
ZacksGear Up for Haemonetics (HAE) Q4 Earnings: Wall Street Estimates for Key Metrics
ZacksHaemonetics (HAE) Earnings Expected to Grow: Should You Buy?
PR NewswireHaemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2025 Results: May 8, 2025
PR NewswireHaemonetics Announces Executive Leadership Updates
PR NewswireHaemonetics to Present at Raymond James 46th Annual Institutional Investors Conference
PR NewswireHaemonetics 3rd Quarter Fiscal Year 2025 Earnings Release Available on Investor Relations Website
PR NewswireHaemonetics Completes Sale of Whole Blood Assets to GVS, S.p.A
PR NewswireHaemonetics Sets Date for Publishing Third Quarter Fiscal Year 2025 Results: February 6, 2025
PR NewswireHaemonetics to Present at 43rd Annual J.P. Morgan Healthcare Conference
PR NewswireHaemonetics Announces Sale of Whole Blood Assets to GVS, S.p.A
PR NewswireHaemonetics 2nd Quarter Fiscal Year 2025 Earnings Release Available on Investor Relations Website
PR NewswireHaemonetics Sets Date for Publishing Second Quarter Fiscal Year 2025 Results: November 7, 2024
PR NewswireHaemonetics Announces Full Market Release for VASCADE MVP® XL Vascular Closure System
PR NewswireHaemonetics 1st Quarter Fiscal Year 2025 Earnings Release Available on Investor Relations Website
PR NewswireHaemonetics Announces CE Mark Certification for the SavvyWire® Pre-Shaped Pressure Guidewire
PR NewswireHaemonetics Announces CE Mark Certification for the SavvyWire® Pre-Shaped Pressure Guidewire
PR NewswireHaemonetics Sets Date for Publishing First Quarter Fiscal Year 2025 Results: August 8, 2024
PR NewswireHaemonetics Launches Limited Market Release for New VASCADE MVP XL Vascular Closure Device
PR NewswireHaemonetics 4th Quarter and Fiscal Year 2024 Earnings Release Available on Investor Relations Website
PR NewswireHaemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2024 Results: May 9, 2024
PR NewswireHaemonetics Receives FDA Clearance for New TEG® 6s Global Hemostasis - HN Cartridge
PR NewswireHaemonetics Corporation Completes Acquisition of Attune Medical
PR NewswireHaemonetics Announces Definitive Agreement to Acquire Attune Medical
PR NewswireHaemonetics to Present at Raymond James 45th Annual Institutional Investors Conference
PR NewswireHaemonetics to Present at Citi's 2024 Unplugged Medtech and Life Sciences Access Day

Haemonetics News

Haemonetics News: auf dieser Seite finden Sie alle Haemonetics News und Nachrichten zur Haemonetics Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Haemonetics News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Haemonetics News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.